ProfileGDS5678 / 1430152_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 51% 53% 53% 55% 52% 58% 52% 57% 52% 53% 52% 53% 52% 53% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2955751
GSM967853U87-EV human glioblastoma xenograft - Control 23.2864253
GSM967854U87-EV human glioblastoma xenograft - Control 33.3054353
GSM967855U87-EV human glioblastoma xenograft - Control 43.3142155
GSM967856U87-EV human glioblastoma xenograft - Control 53.2278952
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5733758
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3547652
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4476157
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2495752
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2729253
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2560352
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.276253
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2650552
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2915553